Pfizer opens cholesterol drug facility
27 June 2005 00:01 [Source: ICB Americas]
Pfizer has brought on-stream a new facility in Loughbeg, Ireland, dedicated to the production of torcetrapib, a compound being studied in combination with the cholesterol-lowering drug Lipitor (atorvastatin).
The company invested $90 million to expand the Loughbeg facility, which will employ 40 people once fully operational. The plant will use spray-dried dispersion, a new dosage form technology developed in conjunction with Bend Research, to formulate the torcetrapib/atorvastatin combination used in the clinical development program.
The combination drug represents a new strategy in the treatment of cardiovascular diseases: while traditional statins like Lipitor act to lower LDL, or “bad” cholesterol, torcetrapib works to raise levels of HDL, or “good” cholesterol.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
Related Articles
- 17 Dec 08 00:00 Hovione buys Pfizer's Loughbeg API facility
- 21 Jan 08 00:00 Patients treated with Lipitor were significantly less likely to have a cardiovascular event than those treated with simvastatin, new observational study shows
- 18 Dec 06 00:00 Drug industry stumbles
- 22 Mar 06 00:00 New torcetrapib/atorvastatin research further supports raising 'good' HDL cholesterol.
- 09 Dec 05 00:00 A second bullet for cholesterol. [1 table]
- 23 Nov 05 00:00 Pfizer's Torcetrapib/Atorvastatin significantly raised 'good' cholesterol while lowering 'bad' cholesterol, new data show.
- 13 Jul 05 00:00 Pfizer opens new production line in Ireland.
- 06 Jul 05 00:00 Pfizer opens cholesterol drug facility.
- 29 Jun 05 00:00 Pfizer begins production at torcetrapib/atorvastatin manufacturing facility; major milestone for potential cardiovascular medicine.
- 14 Mar 05 00:01 Can the Slumping Pharmaceutical Industry Rebound?
Latest News
- 20 May 13 17:42 US WEC begins engineering phase of $100m Whitetail Refinery in Texas
- 20 May 13 17:25 US shale-related capital projects to boost jobs, tax revenues
- 20 May 13 17:01 EVENING SNAPSHOT – Europe Markets Summary
- 20 May 13 16:52 US ethylene margins jump 5.7% on increase in spot values
- 20 May 13 16:49 Saudi SABIC opens thermoplastics, PP compounding facility in Jubail